Skip to main content
. 2020 Jul 9;14:1753466620938553. doi: 10.1177/1753466620938553

Figure 9.

Figure 9.

Efficiency of larotrectinib in diverse tumors (updated comprehensive data set, 2018). The overall response is 81% and the complete response 17%.